AFIB

Acutus Medical, Inc. (AFIB) | Rumor.io

Acutus Medical

AFIB

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about AFIB?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Nov 8

Acutus Medical, Inc. ($AFIB) insiders control over 80% of shares, with a manufacturing contract with Medtronic worth over $2 billion.
The company is nearing profitability, with earnouts expected to show sales momentum from AcqCross sales, potentially causing shares to jump above $1+.
Market cap has decreased significantly due to irrational selling, with insiders buying up shares, and market makers PUMA and CFGN being dilutive.

Generated by AI

Sentiment

Of the messages about AFIB that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	50% -29.3
Bearish	—	—	—	50% +29.3

Bullish· Jan 25

Acutus Medical, Inc. ($AFIB) has a patent that is seen as solid, which could lead to the stock rising.
The company has been growing quarter over quarter, with corporate restructuring to maximize profit recently.
The stock has a significant number of short sellers, which could be forced to cover their positions, leading to a rise in the stock's price.

Bearish· Nov 3

The asset's price is expected to drop to $1.50, causing losses for investors who didn't buy in at the current price.
The company's short funds are trying to drive the stock price down, and it's likely that they still have a significant amount of shares to unload.
The asset's momentum indicator has dropped below the 0 level, indicating a downtrend and a high likelihood of further price declines.

Generated by AI

Topics

Of the messages about AFIB that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	66.67%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	33.33%

Announcements· Jan 25

Acutus Medical shares surged 45% premarket after being granted European Patent number EP3043701.
The patent, titled "Devices And Methods For Determination Of Electrical Dipole Densities On A Cardiac Surface," could have significant implications for the company's business.
The patent grant may contribute to increased profits for Acutus Medical, particularly in the European market.

Technical Analysis· Jun 27

The next target for $AFIB is $1.50, with $1.10 serving as support.
A break above $1.10 is needed for $AFIB to move higher, with a potential setup for a breakout.
$AFIB is forming a pennant pattern and is moving higher on low volume, potentially setting it up for a run past $1.5 to $2.

Generated by AI

Community

Of the messages about AFIB, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	78.95%
Newcomers	—	—	—	21.05%

Regulars· Jan 25

The regulars are closely watching Acutus Medical, Inc. (AFIB) for its strong trending performance, with a 43.3% increase so far.
The stock's float is relatively low at 18.5M, which may be a contributing factor to its continued upward momentum.
Acutus Medical, Inc. has a significant amount of its shares already traded, with 28.3M shares traded on the current day, indicating high market interest.

Newcomers· Feb 21

Newcomers to $AFIB are focusing on its potential to reach new price targets, with some already hitting the first target at 0.37.
The asset's historical runs have shown a consistent pattern of reaching a supply zone above, and current momentum and volume are still intact.
Some users are considering $AFIB as a strong overnight trading candidate, with one user already reaching a price of 0.444, and another user anticipating a potential PM gap.

Generated by AI

Also Discussed

Investors talking about AFIB also mention

#	Name	Attention
1	Stereotaxis Inc.STXS	0%0
2	United Maritime CorporationUSEA	0%0
3	Getaround, Inc.GETR	0%new
4	Comera Life Sciences Holdings Inc.CMRA	0%0
5	RNLX - Renalytix Plc	——
6	Guardforce AI Co., Ltd.GFAI	0%0
7	Lixte Biotechnology Holdings Inc.LIXT	0%new
8	VEDU - Visionary Holdings Inc.	——
9	Apollomics Inc.APLM	0%0
10	KSPN - Kaspien Holdings Inc.	——

Acutus Medical, Inc.

Location

Social

What share of all stock conversation is about AFIB?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Nov 8

Acutus Medical, Inc. ($AFIB) insiders control over 80% of shares, with a manufacturing contract with Medtronic worth over $2 billion.
The company is nearing profitability, with earnouts expected to show sales momentum from AcqCross sales, potentially causing shares to jump above $1+.
Market cap has decreased significantly due to irrational selling, with insiders buying up shares, and market makers PUMA and CFGN being dilutive.

Generated by AI

Sentiment

Of the messages about AFIB that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	50% -29.3
Bearish	—	—	—	50% +29.3

Bullish· Jan 25

Acutus Medical, Inc. ($AFIB) has a patent that is seen as solid, which could lead to the stock rising.
The company has been growing quarter over quarter, with corporate restructuring to maximize profit recently.
The stock has a significant number of short sellers, which could be forced to cover their positions, leading to a rise in the stock's price.

Bearish· Nov 3

The asset's price is expected to drop to $1.50, causing losses for investors who didn't buy in at the current price.
The company's short funds are trying to drive the stock price down, and it's likely that they still have a significant amount of shares to unload.
The asset's momentum indicator has dropped below the 0 level, indicating a downtrend and a high likelihood of further price declines.

Generated by AI

Topics

Of the messages about AFIB that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	66.67%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	33.33%

Announcements· Jan 25

Acutus Medical shares surged 45% premarket after being granted European Patent number EP3043701.
The patent, titled "Devices And Methods For Determination Of Electrical Dipole Densities On A Cardiac Surface," could have significant implications for the company's business.
The patent grant may contribute to increased profits for Acutus Medical, particularly in the European market.

Technical Analysis· Jun 27

The next target for $AFIB is $1.50, with $1.10 serving as support.
A break above $1.10 is needed for $AFIB to move higher, with a potential setup for a breakout.
$AFIB is forming a pennant pattern and is moving higher on low volume, potentially setting it up for a run past $1.5 to $2.

Generated by AI

Community

Of the messages about AFIB, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	78.95%
Newcomers	—	—	—	21.05%

Regulars· Jan 25

The regulars are closely watching Acutus Medical, Inc. (AFIB) for its strong trending performance, with a 43.3% increase so far.
The stock's float is relatively low at 18.5M, which may be a contributing factor to its continued upward momentum.
Acutus Medical, Inc. has a significant amount of its shares already traded, with 28.3M shares traded on the current day, indicating high market interest.

Newcomers· Feb 21

Newcomers to $AFIB are focusing on its potential to reach new price targets, with some already hitting the first target at 0.37.
The asset's historical runs have shown a consistent pattern of reaching a supply zone above, and current momentum and volume are still intact.
Some users are considering $AFIB as a strong overnight trading candidate, with one user already reaching a price of 0.444, and another user anticipating a potential PM gap.

Generated by AI

Acutus Medical

Social

Nov 8

Sentiment

Bullish· Jan 25

Bearish· Nov 3

Topics

Announcements· Jan 25

Technical Analysis· Jun 27

Community

Regulars· Jan 25

Newcomers· Feb 21

Also Discussed

Acutus Medical, Inc.

Company Information

Location

Also Discussed

Social

Nov 8

Sentiment

Bullish· Jan 25

Bearish· Nov 3

Topics

Announcements· Jan 25

Technical Analysis· Jun 27

Community

Regulars· Jan 25

Newcomers· Feb 21